RA Capital Management »

Mirum Pharmaceuticals shares owned by RA Capital Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $29M 319k 92.38

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
Vanguard Capital Management
State Street Corporation
Eventide Asset Management
BVF
Vanguard Portfolio Management
Novo A/S
Geode Capital Management
Wellington Management Company
Tang Capital Management
Citadel Advisors
TCG Crossover Management

View all funds holding Mirum Pharmaceuticals